An evaluation of 2 prothrombin time/international normalized ratio point-of-care devices in clinical practice: A comparison to the central laboratory international normalized ratio

Nathaniel Rand, Caryn Sands, Vilma Padilla, Khrishan Naraine, Amy S. Fox

Research output: Contribution to journalArticle

Abstract

It is essential that patients receiving anticoagulant treatment with vitamin K antagonists such as warfarin are appropriately monitored using international normalized ratio (INR) results. International normalized ratio results, which are calculated from prothrombin time (PT) determinations, have become the standard unitage for reporting PT results. Typically, blood samples are sent to central laboratories to test plasmas for PT and INR; however, there are many limitations to central laboratory testing. Point-of-care (POC) instruments have been developed to help address many of the problems that exist with centralized laboratory testing-in particular, the efficiency of reporting the result to the patient's health care provider. The purpose of this study was to compare the accuracy of 2 POC devices (HemoSense INRatio System and the ITC Hemochron Jr Signature +) with a standard laboratory plasma coagulation system (Dade Behring BCS with Innovin) in a "real-world" setting. Also, an assessment of clinical accuracy with respect to the appropriate intensity of anticoagulation was determined. A total of 134 patients were tested (76 with HemoSense System and 58 with Hemochron device). We found that both POC instruments showed significant limitations in accuracy compared with the central laboratory method. The POC instruments would have resulted in about 30% misdiagnoses of the patients' therapeutic status. This could potentially result in inappropriate treatment decisions and dose adjustments, especially because there is a relatively narrow therapeutic range for this class of anticoagulants. In conclusion, the results generated by these POC devices are subject to significant limitations.

Original languageEnglish (US)
Pages (from-to)98-101
Number of pages4
JournalPoint of Care
Volume9
Issue number2
DOIs
StatePublished - Jun 2010

Fingerprint

Point-of-Care Systems
International Normalized Ratio
Prothrombin Time
Equipment and Supplies
Anticoagulants
Vitamin K
Warfarin
Therapeutics
Diagnostic Errors
Health Personnel
Patient Care

Keywords

  • Anticoagulation
  • International normalized ratio
  • Point-of-care testing
  • Prothrombin time

ASJC Scopus subject areas

  • Nursing(all)

Cite this

An evaluation of 2 prothrombin time/international normalized ratio point-of-care devices in clinical practice : A comparison to the central laboratory international normalized ratio. / Rand, Nathaniel; Sands, Caryn; Padilla, Vilma; Naraine, Khrishan; Fox, Amy S.

In: Point of Care, Vol. 9, No. 2, 06.2010, p. 98-101.

Research output: Contribution to journalArticle

@article{f2cd8115951c4d49a34fd7dcdfc5166a,
title = "An evaluation of 2 prothrombin time/international normalized ratio point-of-care devices in clinical practice: A comparison to the central laboratory international normalized ratio",
abstract = "It is essential that patients receiving anticoagulant treatment with vitamin K antagonists such as warfarin are appropriately monitored using international normalized ratio (INR) results. International normalized ratio results, which are calculated from prothrombin time (PT) determinations, have become the standard unitage for reporting PT results. Typically, blood samples are sent to central laboratories to test plasmas for PT and INR; however, there are many limitations to central laboratory testing. Point-of-care (POC) instruments have been developed to help address many of the problems that exist with centralized laboratory testing-in particular, the efficiency of reporting the result to the patient's health care provider. The purpose of this study was to compare the accuracy of 2 POC devices (HemoSense INRatio System and the ITC Hemochron Jr Signature +) with a standard laboratory plasma coagulation system (Dade Behring BCS with Innovin) in a {"}real-world{"} setting. Also, an assessment of clinical accuracy with respect to the appropriate intensity of anticoagulation was determined. A total of 134 patients were tested (76 with HemoSense System and 58 with Hemochron device). We found that both POC instruments showed significant limitations in accuracy compared with the central laboratory method. The POC instruments would have resulted in about 30{\%} misdiagnoses of the patients' therapeutic status. This could potentially result in inappropriate treatment decisions and dose adjustments, especially because there is a relatively narrow therapeutic range for this class of anticoagulants. In conclusion, the results generated by these POC devices are subject to significant limitations.",
keywords = "Anticoagulation, International normalized ratio, Point-of-care testing, Prothrombin time",
author = "Nathaniel Rand and Caryn Sands and Vilma Padilla and Khrishan Naraine and Fox, {Amy S.}",
year = "2010",
month = "6",
doi = "10.1097/POC.0b013e3181d9f050",
language = "English (US)",
volume = "9",
pages = "98--101",
journal = "Point of Care",
issn = "1533-029X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - An evaluation of 2 prothrombin time/international normalized ratio point-of-care devices in clinical practice

T2 - A comparison to the central laboratory international normalized ratio

AU - Rand, Nathaniel

AU - Sands, Caryn

AU - Padilla, Vilma

AU - Naraine, Khrishan

AU - Fox, Amy S.

PY - 2010/6

Y1 - 2010/6

N2 - It is essential that patients receiving anticoagulant treatment with vitamin K antagonists such as warfarin are appropriately monitored using international normalized ratio (INR) results. International normalized ratio results, which are calculated from prothrombin time (PT) determinations, have become the standard unitage for reporting PT results. Typically, blood samples are sent to central laboratories to test plasmas for PT and INR; however, there are many limitations to central laboratory testing. Point-of-care (POC) instruments have been developed to help address many of the problems that exist with centralized laboratory testing-in particular, the efficiency of reporting the result to the patient's health care provider. The purpose of this study was to compare the accuracy of 2 POC devices (HemoSense INRatio System and the ITC Hemochron Jr Signature +) with a standard laboratory plasma coagulation system (Dade Behring BCS with Innovin) in a "real-world" setting. Also, an assessment of clinical accuracy with respect to the appropriate intensity of anticoagulation was determined. A total of 134 patients were tested (76 with HemoSense System and 58 with Hemochron device). We found that both POC instruments showed significant limitations in accuracy compared with the central laboratory method. The POC instruments would have resulted in about 30% misdiagnoses of the patients' therapeutic status. This could potentially result in inappropriate treatment decisions and dose adjustments, especially because there is a relatively narrow therapeutic range for this class of anticoagulants. In conclusion, the results generated by these POC devices are subject to significant limitations.

AB - It is essential that patients receiving anticoagulant treatment with vitamin K antagonists such as warfarin are appropriately monitored using international normalized ratio (INR) results. International normalized ratio results, which are calculated from prothrombin time (PT) determinations, have become the standard unitage for reporting PT results. Typically, blood samples are sent to central laboratories to test plasmas for PT and INR; however, there are many limitations to central laboratory testing. Point-of-care (POC) instruments have been developed to help address many of the problems that exist with centralized laboratory testing-in particular, the efficiency of reporting the result to the patient's health care provider. The purpose of this study was to compare the accuracy of 2 POC devices (HemoSense INRatio System and the ITC Hemochron Jr Signature +) with a standard laboratory plasma coagulation system (Dade Behring BCS with Innovin) in a "real-world" setting. Also, an assessment of clinical accuracy with respect to the appropriate intensity of anticoagulation was determined. A total of 134 patients were tested (76 with HemoSense System and 58 with Hemochron device). We found that both POC instruments showed significant limitations in accuracy compared with the central laboratory method. The POC instruments would have resulted in about 30% misdiagnoses of the patients' therapeutic status. This could potentially result in inappropriate treatment decisions and dose adjustments, especially because there is a relatively narrow therapeutic range for this class of anticoagulants. In conclusion, the results generated by these POC devices are subject to significant limitations.

KW - Anticoagulation

KW - International normalized ratio

KW - Point-of-care testing

KW - Prothrombin time

UR - http://www.scopus.com/inward/record.url?scp=77953106850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953106850&partnerID=8YFLogxK

U2 - 10.1097/POC.0b013e3181d9f050

DO - 10.1097/POC.0b013e3181d9f050

M3 - Article

AN - SCOPUS:77953106850

VL - 9

SP - 98

EP - 101

JO - Point of Care

JF - Point of Care

SN - 1533-029X

IS - 2

ER -